From professional translators, enterprises, web pages and freely available translation repositories.
nomename of the containing folder
nombrename of the containing folder
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
annullaall collections containing recipients.
& cancelarall collections containing recipients.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
@title: tab tab containing general ui settings
802.1x@title: tab tab containing general ui settings
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
archiviazione@title: column column containing message subjects
archivando@title: column column containing message subjects
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
id utente@title: column column containing email addresses
id de usuario@title: column column containing email addresses
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
stato@title: column column containing title of the person
estado@title: column column containing title of the person
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
& tipo di connessione: @title: tab tab containing menu tooltip settings
& secretas de la conexión@title: tab tab containing menu tooltip settings
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
spc for antimicrobial products demonstration of efficacy for veterinary medicinal products containing antimicrobial subsatnces
spc for antimicrobial products demonstration of efficacy for veterinary medicinal products containing antimicrobial subsatnces
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance
note for guidance on comparability of medicinal products containing biotechnology-derived proteins as drug substance
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on quality aspects of medicinal products containing active substances produced by stable transgene experession in higher plants
points to consider on quality aspects of medicinal products containing active substances produced by stable transgene experession in higher plants
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
you can add it right clicking and selecting 'upload' or add the containing folder in the memopal configuration wizard
puede agregarla al hacer clic con el botón derecho y seleccionar "cargar", o bien puede agregar la carpeta en el asistente de configuración de memopal.
Last Update: 2008-04-29
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
- elaborazione di una strategia di rimozione delle masse contenenti combustibile (fuel containing masses - fcm);
· elaborar una estrategia a largo plazo de retirada de las masas que contienen combustible (fcm - "fuel containing masses");
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
to prove that a notice has been sent , it shall be sufficient to prove that the notice was delivered to the relevant address or that the envelope containing such notice was properly addressed and posted .
to prove that a notice has been sent , it shall be sufficient to prove that the notice was delivered to the relevant address or that the envelope containing such notice was properly addressed and posted .
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
titolo del documento note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
título del documento note for guidance on the use of bovine serum in the manufacture of human biological medicinal products points to consider on quality aspects of medicinal products containing active substances produced by stable transgene expression in higher plants revision of note for guidance on minimising the risks of tse transmission via medicinal products points to consider on the development of live attenuated influenza vaccines
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
63) note for guidance on photosafety testing points to consider document on the need for assessment of reproductive toxicity of human insulin analogues discussion paper on environmental risk assessments of non-gmo containing medicinal products for human use non-clinical documentation of medicinal products with ‘ well-established use’ note for guidance on the need for non-clinical testing of pharmaceuticals in juvenile animals discussion paper on the non-clinical safety studies to support single low dose clinical screening studies in man note for guidance on specification limits for residues for heavy metal catalysts in medicinal products points to consider on xenogeneic cell therapy note for guidance on comparability of biotechnology products pre-clinical and clinical issues points to consider on the assessment of the potential for qt interval prolongation by non-cardiovascular medicinal products note for guidance on risk assessment of medicinal products on human reproductive and development toxicities: from data to labelling
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.